Aerosol Route Research Articles

Immunization efficacy and safety of Brucella 104M against aerosol challenge in BALB/c mice

Objective: To evaluate the protective efficacy and safety of Brucella 104M against aerosol challenge in BALB/c mice and characterize its immunological effects. Methods: Female mice of 6-8 weeks old were immunized with Brucella abortus strain 104M by intratracheal aerosol delivery or intranasal instillation or subcutaneous injection route. Six mice of each group were sacrificed at 4, 8, 16, 24 weeks after immunization. At each time point, the clinical manifestations of mice were investigated, the serum, spleen and lung samples of mice were collected, body weight, spleen weight, bacteria loads in spleens, the anti-Brucella antibodies titers in serum and the cytokines concentrations of IFN-γ, IL-18 in serum or lung homogenate of the mice were detected. Twenty two weeks after immunization, all the mice were challenged with Brucella A19 through intratracheal aerosol delivery. Results: Compared with the control group, neither abnormal clinical symptoms nor significant changes in body weight were found in 104M immunization groups, at each time point when immunized through either nose dropping route, subcutaneous injection or aerosol routes; and the spleen weight of immunization groups were lower than control group after challenge (P<0.05): *M1 (0.26±0.16)g<M2 (0.40±0.19)g; *M3(0.21±0.11)g<M4(0.28±0.19)g; *M5(0.14±0.02)g<M6 (0.30±0.18)g. The spleen bacterium load of the mice in 104M immunization groups decreased until 20 weeks later, the cells were completely clear out, 2 weeks after challenge (24 weeks), the bacterium load increased again, the bacterium load in immunization groups were significantly lower than that in control group (P<0.05): *M1(4.49±0.13)log(10) (Colony-Forming Units) CFU/g<M2(6.90±0.46)log(10)CFU/g; *M3(3.59±1.06)log(10)CFU/g<M4(7.08±0.14) log(10)CFU/g; *M5(3.00±2.03)log(10)CFU/g<M6(6.81±0.34)log(10)CFU/g. The high titer of Brucella 104M specific antibodies were detected at week 4, and the peak was reached at week 8 of immunization groups. At each time point, the serum antibody titers IgG 2a was higher than that of IgG 1; before challenge, the cytokines concentrations of IFN-γ and IL-18 in all immunization groups were significantly higher than that in control group (P<0.05), after challenge, cytokines concentrations of IFN-γ and IL-18 in the serum were lower in all immunization groups than in control group (P<0.05). At each time point, IFN-γ, IL-1βand IL-18 concentrations in lung homogenate were higher in immunization groups than in control group (P<0.05). There were no significant differences among the three immunization routes in all sample detection indexes (P<0.05). Conclusions: Intratracheal aerosol delivery is a safe and effective immunization route in BALB/c mice. Both humoral immunity and cellular immunity were stimulated by Brucella 104M, showing obvious protective efficacy against aerosol challenge in BALB/c mice. No significant weight loss was detected. However, the colonizing of Brucella 104M in the spleen of mice was too long (20 weeks), and slighter spleen swelling of the mice were detected, which illustrated that the attenuated strain 104M has residual virulence as a vaccine strain in mice.

Guidance for the management of adult patients with coronavirus disease 2019.

In December 2019, a novel coronavirus was identified in Wuhan City, Hubei Province, China and later the disease was named coronavirus disease 2019 (COVID-19). On March 11, 2020, the World Health Organization (WHO) officially announced that COVID-19 had reached global pandemic status. This article summarized the understanding of the etiology, pathogenesis, epidemiology, clinical characteristics, diagnosis, treatment, rehabilitation, and prevention and control measures of COVID-19 based on the available data and anti-epidemic experience in China.

Design and evaluation of a portable negative pressure hood with HEPA filtration to protect health care workers treating patients with transmissible respiratory infections

BackgroundTo mitigate potential exposure of healthcare workers (HCWs) to SARS-CoV-2 via aerosol routes, we have developed a portable hood which not only creates a barrier between HCW and patient, but also utilizes negative pressure with filtration of aerosols by a high-efficiency particulate air filter. Material and MethodsThe hood has iris-port openings for access to the patient, and an opening large enough for a patient's head and upper torso. The top of the hood is a high-efficiency particulate air filter connected to a blower to apply negative pressure. We determined the aerosol penetration from outside to inside in laboratory experiments. ResultsThe penetration of particles from within the hood to the breathing zones of HCWs outside the hood was near 10-4 (0.01%) in the 200-400 nm size range, and near 10−3 (0.1%) for smaller particles. Penetration values for particles in the 500 nm-5 μm range were below 10−2 (1%). Fluorometric analysis of deposited fluorescein particles on the personal protective equipment of an HCW revealed that negative pressure reduces particle deposition both outside and inside the hood. ConclusionsWe find that negative pressure hoods can be effective controls to mitigate aerosol exposure to HCWs, while simultaneously allowing access to patients.

Infection Risk Assessment of COVID-19 through Aerosol Transmission: a Case Study of South China Seafood Market.

The Corona Virus Disease 2019 (COVID-19) is rapidly spreading throughout the world. Aerosol is a potential transmission route. We conducted the quantitative microbial risk assessment (QMRA) to evaluate the aerosol transmission risk by using the South China Seafood Market as an example. The key processes were integrated, including viral shedding, dispersion, deposition in air, biologic decay, lung deposition, and the infection risk based on the dose–response model. The available hospital bed for COVID-19 treatment per capita (1.17 × 10–3) in Wuhan was adopted as a reference for manageable risk. The median risk of a customer to acquire SARS-CoV-2 infection via the aerosol route after 1 h of exposure in the market with one infected shopkeeper was about 2.23 × 10–5 (95% confidence interval: 1.90 × 10–6 to 2.34 × 10–4). The upper bound could increase and become close to the manageable risk with multiple infected shopkeepers. More detailed risk assessment should be conducted in poorly ventilated markets with multiple infected cases. The uncertainties were mainly due to the limited information on the dose–response relation and the viral shedding which need further studies. The risk rapidly decreased outside the market due to the dilution by ambient air and became below 10–6 at 5 m away from the exit.

Aerosols May Be at the Core of COVID-19 Transmission

After the initial reluctance to recognise the aerosol transmission route as being of any significant importance in COVID-19, the scientific community seems to have settled upon the idea that it has probably been important in certain indoor superspreader events. This paper puts forward additional lines of evidence suggesting that the aerosol route is not just indispensable for explaining such events but may well be the dominant transmission route of the disease. We also turn on its head the main objection to the aerosol route’s importance, namely, that it would imply much larger spread than what has so far been observed. Building on recent experimental studies on influenza and evidence on COVID-19, we discuss evidence that COVID-19 may only or mostly be spread by the minority of infected with significant lung involvement, who exhale enough infectious aerosol.

Atypical Neurological Manifestations of COVID-19.

The novel coronavirus (SARS-CoV-2), belonging to a group of RNA-enveloped viruses and believed to be transmitted by aerosol route, is a worldwide pandemic. Many studies have described typical clinical manifestations such as fever, cough, fatigue, diarrhea, and nasal congestion. However, to our knowledge, there are minimal studies on the neurological manifestations in SARS-CoV-2 positive patients. Our review aims to identify the various neurological manifestations in SARS-CoV-2 positive patients, which could be an added advantage in the early diagnosis and prevention of further complications of the nervous system.

Aerosol generating procedures, dysphagia assessment and COVID-19: A rapid review.

Aerosol generating procedures, dysphagia assessment and COVID-19: A rapid review.

Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 via Close Contact and Respiratory Droplets Among Human Angiotensin-Converting Enzyme 2 Mice.

We simulated 3 transmission modes, including close-contact, respiratory droplets and aerosol routes, in the laboratory. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be highly transmitted among naive human angiotensin-converting enzyme 2 (hACE2) mice via close contact because 7 of 13 naive hACE2 mice were SARS-CoV-2 antibody seropositive 14 days after being introduced into the same cage with 3 infected-hACE2 mice. For respiratory droplets, SARS-CoV-2 antibodies from 3 of 10 naive hACE2 mice showed seropositivity 14 days after introduction into the same cage with 3 infected-hACE2 mice, separated by grids. In addition, hACE2 mice cannot be experimentally infected via aerosol inoculation until continued up to 25 minutes with high viral concentrations.

Lung-resident memory CD8+ T cells prevent transmission of respiratory viruses

Abstract Lung tissue-resident memory CD8+ T cells (TRM) reduce viral replication and limit pathology following respiratory virus infections. In particular, TRM are crucial for protection against infections with heterosubtypic influenza viruses, where pre-existing antibody does not provide sterilizing immunity. In addition to providing individual host immunity, vaccination programs are designed to limit pathogen spread at population level. Despite the interest in lung TRM for intra-host protective immunity, their effect on the transmission respiratory viruses has been understudied due to the lack of animal models where influenza infection can be tracked longitudinally, and where the immunological parameters are easily identified and manipulated. To circumvent these issues, we used a luciferase-expressing Sendai virus, a natural mouse parainfluenza virus that readily transmits via the aerosol and contact routes, to evaluate the efficacy of lung TRM against transmission of respiratory viruses. Using a recombinant influenza virus expressing the immunodominant SenNP324–332Kb epitope to generate SenNP+ memory CD8+ T cells and IVIS imaging to non-invasively measure Sendai virus infection over time, we found that mice with pre-existing SenNP+ lung TRM don’t transmit Sendai virus to naïve mice when co-housed. In contrast, immunized mice that had pre-existing circulating effector memory CD8+ T cells (TEM), but no lung TRM, failed to prevent transmission of Sendai virus to naïve mice when co-housed. These results show the ability of lung TRM to contribute to herd immunity by preventing respiratory virus transmission and underscore the potential of a TRM-inducing vaccine for protection against respiratory viruses.

Production of Neutrophil Extracellular Traps Contributes to the Pathogenesis of Francisella tularemia.

Francisella tularensis(Ft) is a highly virulent, intracellular Gram-negative bacterial pathogen. Acute Ft infection by aerosol route causes pneumonic tularemia, characterized by nodular hemorrhagic lesions, neutrophil-predominant influx, necrotic debris, fibrin deposition, and severe alveolitis. Ft suppresses activity of neutrophils by impairing their respiratory burst and phagocytic activity. However, the fate of the massive numbers of neutrophils recruited to the infection site is unclear. Here, we show that Ft infection resulted in prominent induction of neutrophil extracellular traps (NETs) within damaged lungs of mice infected with the live attenuated vaccine strain of Ft(Ft-LVS), as well as in the lungs of domestic cats and rabbits naturally infected with Ft. Further, Ft-LVS infection increased lung myeloperoxidase (MPO) activity, which mediates histone protein degradation during NETosis and anchors chromatin scaffolds in NETs. In addition, Ft infection also induced expression of peptidylarginine deiminase 4, an enzyme that causes citrullination of histones during formation of NETs. The released NETs were found largely attached to the alveolar epithelium, and disrupted the thin alveolar epithelial barrier. Furthermore, Ft infection induced a concentration-dependent release of NETs from neutrophils in vitro. Pharmacological blocking of MPO reduced Ft-induced NETs release, whereas addition of H2O2 (a substrate of MPO) significantly augmented NETs release, thus indicating a critical role of MPO in Ft-induced NETs. Although immunofluorescence and electron microscopy revealed that NETs could efficiently trap Ft bacteria, NETs failed to exert bactericidal effects. Taken together, these findings suggest that NETs exacerbate tissue damage in pulmonary Ft infection, and that targeting NETosis may offer novel therapeutic interventions in alleviating Ft-induced tissue damage.

Characterization of Schu S4 aro mutants as live attenuated tularemia vaccine candidates

ABSTRACT There is a need for development of an effective vaccine against Francisella tularensis, as this potential bioweapon has a high mortality rate and low infectious dose when delivered via the aerosol route. Moreover, this Tier 1 agent has a history of weaponization. We engineered targeted mutations in the Type A strain F. tularensis subspecies tularensis Schu S4 in aro genes encoding critical enzymes in aromatic amino acid biosynthesis. F. tularensis Schu S4ΔaroC, Schu S4ΔaroD, and Schu S4ΔaroCΔaroD mutant strains were attenuated for intracellular growth in vitro and for virulence in vivo and, conferred protection against pulmonary wild-type (WT) F. tularensis Schu S4 challenge in the C57BL/6 mouse model. F. tularensis Schu S4ΔaroD was identified as the most promising vaccine candidate, demonstrating protection against high-dose intranasal challenge; it protected against 1,000 CFU Schu S4, the highest level of protection tested to date. It also provided complete protection against challenge with 92 CFU of a F. tularensis subspecies holarctica strain (Type B). Mice responded to vaccination with Schu S4ΔaroD with systemic IgM and IgG2c, as well as the production of a functional T cell response as measured in the splenocyte-macrophage co-culture assay. This vaccine was further characterized for dissemination, histopathology, and cytokine/chemokine gene induction at defined time points following intranasal vaccination which confirmed its attenuation compared to WT Schu S4. Cytokine, chemokine, and antibody induction patterns compared to wild-type Schu S4 distinguish protective vs. pathogenic responses to F. tularensis and elucidate correlates of protection associated with vaccination against this agent.

Ex‐vivo Effects of Limonene in Airways and Vasculature in Allergic Adenosine A2A receptor Knock‐out and Wild‐type mice

Limonene, a mono‐terpene flavonoid, has anti‐inflammatory effects in asthma by activating A2A adenosine receptors. We studied the effects of inhaled d‐limonene on isolated aortic and tracheal rings from asthmatic mice using tissue/organ bath system. We used mice in which the A2A receptor was genetically knocked out (A2AKO) and C57BLJ/6 (wild‐type; WT) for the study. The mice were divided into control (CON) and allergen‐induced sensitized (SEN), control mice treated with limonene through aerosol route (CON+LIM) and allergen‐induced sensitized mice treated with limonene (SEN+LIM). Mice were sensitized i.p. on days 1, 6 with 20μg ovalbumin (OVA) followed by 5% OVA aerosol challenges on days 11–13. Control groups were given an i.p injection of vehicle (1,6 days) and the aerosol challenge of normal saline (11–13 days). SEN +LIM and CON +LIM groups were given 0.01% limonene in the form of aerosol 90 min prior to the OVA and saline challenge on days 11,12,13. Trachea and aorta were isolated on day 14 for further experiments. Tissue responses were studied in the form of contraction and relaxations in all groups. Treatment with limonene significantly reduced the tracheal reactivity (80.68±20% in SEN+LIM vs SEN; p&lt;0.05) to methacholine (MCh) in WT mice that were allergic. MCh induced tracheal contractions were not altered in A2AKO limonene treated sensitized group compared to non‐treated A2AKO sensitized group (209.87 ± 41.33 A2AKO SEN+LIMSEN+LIM Vs 212.51 ± 43.18 in A2AKO SEN) In presence of A2A‐antagonist (SCH58651), a significant increase in the MCh induced contractility in WT SEN was observed(341.65 ± 2.664 SEN+SCH Vs 225.99 ± 67.34 SEN, pP&lt;0.05). A2A agonist CGS 21680 induced relaxation in WT CON was abolished in WT SEN but restored in WT SEN+LIM (37.8± 16.4% Vs 1.2± 11.1 in SEN, p&lt;0.05). The CGS‐induced tracheal relaxation in WT SEN+LIM and SEN groups was increased in the presence of the NADPH inhibitor apocynin (60.58 ± 17.20 SEN; 21.28 ± 16.02 SEN). In the aorta, acetylcholine‐induced aortic relaxation (endothelium‐dependent response) in WT SEN group was significantly lower than controls (29.82 ± 5.62 WT SEN Vs 51.51 ± 30.13 WT CON, p&lt;0.05) with limonene restoring the response (61.56 ± 11.34 WT‐SEN+LIM). CGS 21680 induced aortic relaxation in WT SEN was completely blunted compared to WT CON (5.62±3.72 WT SEN Vs 66.91 ± 6.8 WT‐CON, *p&lt;0.05). Treatment with limonene restored CGS 21680‐induced relaxation in asthmatic mice (63.8 ± 6.32 WT SEN+LIM Vs 5.62± 3.72 SEN) In conclusion, it appears that limonene restores the tracheal and aortic relaxation induced by adenosine‐mediated pathways by activating the A2A receptor in asthmatic mice.Support or Funding InformationSupported by LIU start‐up funds (DSP), HL027339 (SJM)

A Simple Model for the High Temperature Oxidation Kinetics of Silicon Nanoparticle Aggregates

Silicon nanoparticles are an emerging and promising material in many fields including electronics, catalysis, and biomaterial engineering. Synthesis in the gas phase via aerosol routes allows tuning and engineering material features such as primary particle size distribution, agglomerate size distribution, crystallite size, and morphology. Proper control of these features as well as post-synthesis processing such as surface oxidation is very relevant for making the nanoparticles chemically stable. Therefore, a kinetic expression for determining the extent of oxidation in silicon nanoparticles is necessary. Significant work has been devoted to understanding the kinetics of monocrystalline silicon, and generally accepted models such as the one by Deal and Grove provide a very accurate description of bulk silicon oxidation. However, these models are not as accurate for the first hundreds of angstroms of the oxidation. While this might be acceptable for bulk wafers, it has critical results for silicon nanoparticles with diameters around such range. Furthermore, many applications involve silicon nanoparticle aggregates with a shape far away from perfect spheres. For this reason, in this work, we propose an expression for the parabolic oxidation kinetics of polycrystalline silicon nanoparticle aggregates at 1000 °C with surface area in the range of 3 to 19 m2/g. and crystallite sizes from 50 to 70 nm. The activation energy of the process is also reported to be linked to the crystallite size.

A Lethal Aerosol Exposure Model of Nipah Virus Strain Bangladesh in African Green Monkeys.

The high case-fatality rates and potential for use as a biological weapon make Nipah virus (NiV) a significant public health concern. Previous studies assessing the pathogenic potential of NiV delivered by the aerosol route in African green monkeys (AGMs) used the Malaysia strain (NiVM), which has caused lower instances of respiratory illness and person-to-person transmission during human outbreaks than the Bangladesh strain (NiVB). Accordingly, we developed a small particle aerosol model of NiVB infection in AGMs. Consistent with other mucosal AGM models of NiVB infection, we achieved uniform lethality and disease pathogenesis reflective of that observed in humans.

Monogenic, polygenic, and oligogenic familial hypercholesterolemia.

Familial hypercholesterolemia has long been considered a monogenic disorder. However, recent advances in genetic analyses have revealed various forms of this disorder, including polygenic and oligogenic familial hypercholesterolemia. We review the current understanding of the genetic background of this disease. Mutations in multiple alleles responsible for low-density lipoprotein regulation could contribute to the development of familial hypercholesterolemia, especially among patients with mutation-negative familial hypercholesterolemia. In oligogenic familial hypercholesterolemia, multiple rare genetic variations contributed to more severe familial hypercholesterolemia. Familial hypercholesterolemia is a relatively common 'genetic' disorder associated with an extremely high risk of developing coronary artery disease. In addition to monogenic familial hypercholesterolemia, different types of familial hypercholesterolemia, including polygenic and oligogenic familial hypercholesterolemia, exist and have varying degrees of severity. Clinical and genetic assessments for familial hypercholesterolemia and clinical risk stratifications should be performed for accurate diagnosis, as should cascade screening and risk stratification for the offspring of affected patients.

Establishment of BALB/C mouse models of influenza A H1N1 aerosol inhalation

Influenza A (H1N1) is a rapidly spreading acute respiratory illness that remains a worldwide burden on public health. To simulate natural infection routes, BALB/C mice were challenged with the H1N1 virus by aerosol and intranasal instillation routes. We compared the weight change and survival of the mice for 14 consecutive days after infection. The infected mice were euthanized at days 3, 5, 7, and 9 to perform necropsies, lung pathological analyses, viral titers measurement, and lung cytokines examination. The aerosol-treated mice showed clinical symptoms on day 4, obvious lung lesions on day 5, rapid weight loss on day 7, peak virus replication in the lungs on days 7 to 9, and bronchial epithelial hyperplasia on day 9. However, after intranasal instillation, the mice exhibited clinical signs on day 2, rapid weight loss and obvious lung lesions on day 3, and peak virus replication in the lungs on days 3 to 5; no bronchial epithelial hyperplasia was detected. High levels of proinflammatory cytokines and chemokines were detected in the lungs of infected mice by both two routes. Disease and lung lesion progressions were slower in the mice that inhaled H1N1-containing aerosols than in those treated by intranasal instillation, and lung lesions were homogeneous in the aerosol group and heterogeneous in the intranasal group. In this study, BALB/C mouse models of H1N1 virus aerosol inhalation were successfully established and compared with mouse models of intranasal inoculation, aerosol mouse models had an infection route and lung pathology characteristics that more closely resembled those observed in humans.

Minipigs as a neonatal animal model for tuberculosis vaccine efficacy testing

Many vaccines against childhood diseases are administered early after birth, but vaccine development studies frequently test efficacy in adult rather than in neonatal animal models. In countries with endemic tuberculosis (TB), Bacillus Calmette-Guerin (BCG) is administered as part of the neonatal vaccine regimen because it prevents against the disseminated form of TB in children, although it has variable efficacy against pulmonary TB. Several promising new vaccines against TB are currently being tested in adult animal models. Here we evaluated neonatal piglets as an animal model to test vaccine efficacy. For this purpose, minipigs were vaccinated or not with BCG 48 h after birth and their immune response followed longitudinally until adolescence. We characterized the memory and activation phenotype of T cells, cytokine profile, and monocyte activation in response to BCG stimulation from 4 weeks of age into adolescence- age of 24 weeks. Immunological responses in vaccinated and non-vaccinated animals were further monitored upon infection with a low dose exposure to Mycobacterium tuberculosis strain HN878 via the aerosol route. Comparing the immunological response elicited by BCG vaccination in minipigs vs similar studies in infants, suggest that minipigs have the potential to serve as an effective neonatal animal model for vaccine development.

Aerosol route synthesis of Ni-CeO2-Al2O3 hybrid nanoparticle cluster for catalysis of reductive amination of polypropylene glycol

We demonstrated an aerosol-based approach to synthesize Ni-CeO2-Al2O3 hybrid nanostructure as a potent nanopowder catalyst for the production of polyetheramine via reductive amination of polypropylene glycol. The method combines a gas-phase evaporation-induced self-assembly with two-stage thermal treatments of the aerosol particles. The hybrid Ni-CeO2 nanoparticles (NPs) composed of ultrafine, homogeneously-distributed nanocrystallites of metallic Ni and ceria were shown to uniformly decorate on the surface of Al2O3 nanoparticle cluster (NPC). The composition, physical size and surface state of the hybrid nanostructure were tunable by design. It was found that hybridization with Al2O3 or CeO2 enhanced catalytic activity of the Ni catalyst. A high yield of ≈77% of the desired PEA and a high selectivity to primary amine (≈100%) achieved simultaneously. The surface nitridation of Ni catalyst was effectively suppressed via the incorporation with CeO2 NPs. An enhanced operation stability was observed by using the Ni-CeO2-Al2O3 hybrid nanostructure as catalyst in comparison to the Ni-only NP. The work demonstrated a facile route for controlled gas-phase synthesis of hybrid nanopowder catalysts using Al2O3 NPC as the support matrix and CeO2 NP as the promoter to further enhance the performance of Ni catalyst toward reductive amination.

Aerosol Transmission of Gull-Origin Iceland Subtype H10N7 Influenza A Virus in Ferrets.

Subtype H10 influenza A viruses (IAVs) have been recovered from domestic poultry and various aquatic bird species, and sporadic transmission of these IAVs from avian species to mammals (i.e., human, seal, and mink) are well documented. In 2015, we isolated four H10N7 viruses from gulls in Iceland. Genomic analyses showed four gene segments in the viruses were genetically associated with H10 IAVs that caused influenza outbreaks and deaths among European seals in 2014. Antigenic characterization suggested minimal antigenic variation among these H10N7 isolates and other archived H10 viruses recovered from human, seal, mink, and various avian species in Asia, Europe, and North America. Glycan binding preference analyses suggested that, similar to other avian-origin H10 IAVs, these gull-origin H10N7 IAVs bound to both avian-like alpha 2,3-linked sialic acids and human-like alpha 2,6-linked sialic acids. However, when the gull-origin viruses were compared with another Eurasian avian-origin H10N8 IAV, which caused human infections, the gull-origin virus showed significantly higher binding affinity to human-like glycan receptors. Results from a ferret experiment demonstrated that a gull-origin H10N7 IAV replicated well in turbinate, trachea, and lung, but replication was most efficient in turbinate and trachea. This gull-origin H10N7 virus can be transmitted between ferrets through the direct contact and aerosol routes, without prior adaptation. Gulls share their habitat with other birds and mammals and have frequent contact with humans; therefore, gull-origin H10N7 IAVs could pose a risk to public health. Surveillance and monitoring of these IAVs at the wild bird-human interface should be continued.IMPORTANCE Subtype H10 avian influenza A viruses (IAVs) have caused sporadic human infections and enzootic outbreaks among seals. In the fall of 2015, H10N7 viruses were recovered from gulls in Iceland, and genomic analyses showed that the viruses were genetically related with IAVs that caused outbreaks among seals in Europe a year earlier. These gull-origin viruses showed high binding affinity to human-like glycan receptors. Transmission studies in ferrets demonstrated that the gull-origin IAV could infect ferrets, and that the virus could be transmitted between ferrets through direct contact and aerosol droplets. This study demonstrated that avian H10 IAV can infect mammals and be transmitted among them without adaptation. Thus, avian H10 IAV is a candidate for influenza pandemic preparedness and should be monitored in wildlife and at the animal-human interface.

Boosting BCG with proteins or rAd5 does not enhance protection against tuberculosis in rhesus macaques

Tuberculosis (TB) is the leading cause of death from infection worldwide. The only approved vaccine, BCG, has variable protective efficacy against pulmonary TB, the transmissible form of the disease. Therefore, improving this efficacy is an urgent priority. This study assessed whether heterologous prime-boost vaccine regimens in which BCG priming is boosted with either (i) protein and adjuvant (M72 plus AS01E or H56 plus CAF01) delivered intramuscularly (IM), or (ii) replication-defective recombinant adenovirus serotype 5 (Ad5) expressing various Mycobacterium tuberculosis (Mtb) antigens (Ad5(TB): M72, ESAT-6/Ag85b, or ESAT-6/Rv1733/Rv2626/RpfD) administered simultaneously by IM and aerosol (AE) routes, could enhance blood- and lung-localized T-cell immunity and improve protection in a nonhuman primate (NHP) model of TB infection. Ad5(TB) vaccines administered by AE/IM routes following BCG priming elicited ~10–30% antigen-specific CD4 and CD8 T-cell multifunctional cytokine responses in bronchoalveolar lavage (BAL) but did not provide additional protection compared to BCG alone. Moreover, AE administration of an Ad5(empty) control vector after BCG priming appeared to diminish protection induced by BCG. Boosting BCG by IM immunization of M72/AS01E or H56:CAF01 elicited ~0.1–0.3% antigen-specific CD4 cytokine responses in blood with only a transient increase of ~0.5–1% in BAL; these vaccine regimens also failed to enhance BCG-induced protection. Taken together, this study shows that boosting BCG with protein/adjuvant or Ad-based vaccines using these antigens, by IM or IM/AE routes, respectively, do not enhance protection against primary infection compared with BCG alone, in the highly susceptible rhesus macaque model of tuberculosis.